269 related articles for article (PubMed ID: 25770135)
1. Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice.
Al-Barazanji K; McNulty J; Binz J; Generaux C; Benson W; Young A; Chen L
J Pharmacol Exp Ther; 2015 Jun; 353(3):496-504. PubMed ID: 25770135
[TBL] [Abstract][Full Text] [Related]
2. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
[TBL] [Abstract][Full Text] [Related]
3. Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
Nunez DJ; Bush MA; Collins DA; McMullen SL; Gillmor D; Apseloff G; Atiee G; Corsino L; Morrow L; Feldman PL
PLoS One; 2014; 9(4):e92494. PubMed ID: 24699248
[TBL] [Abstract][Full Text] [Related]
4. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
[TBL] [Abstract][Full Text] [Related]
5. APD668, a G protein-coupled receptor 119 agonist improves fat tolerance and attenuates fatty liver in high-trans fat diet induced steatohepatitis model in C57BL/6 mice.
Bahirat UA; Shenoy RR; Goel RN; Nemmani KV
Eur J Pharmacol; 2017 Apr; 801():35-45. PubMed ID: 28274625
[TBL] [Abstract][Full Text] [Related]
6. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet.
Souza-Mello V; Gregório BM; Cardoso-de-Lemos FS; de Carvalho L; Aguila MB; Mandarim-de-Lacerda CA
Clin Sci (Lond); 2010 Jun; 119(6):239-50. PubMed ID: 20415664
[TBL] [Abstract][Full Text] [Related]
8. The effect of metformin on neuronal activity in the appetite-regulating brain regions of mice fed a high-fat diet during an anorectic period.
Kim HJ; Jin BY; Oh MJ; Shin KH; Choi SH; Kim DH
Physiol Behav; 2016 Feb; 154():184-90. PubMed ID: 26631545
[TBL] [Abstract][Full Text] [Related]
9. Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice.
Kim HJ; Zhang XH; Park EY; Shin KH; Choi SH; Chun BG; Kim DH
Physiol Behav; 2013 Feb; 110-111():213-20. PubMed ID: 23391573
[TBL] [Abstract][Full Text] [Related]
10. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
[TBL] [Abstract][Full Text] [Related]
11. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
[TBL] [Abstract][Full Text] [Related]
12. Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice.
Matsui Y; Hirasawa Y; Sugiura T; Toyoshi T; Kyuki K; Ito M
Biol Pharm Bull; 2010; 33(6):963-70. PubMed ID: 20522960
[TBL] [Abstract][Full Text] [Related]
13. The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat.
Hansen HH; Hansen G; Paulsen S; Vrang N; Mark M; Jelsing J; Klein T
Eur J Pharmacol; 2014 Oct; 741():254-63. PubMed ID: 25160746
[TBL] [Abstract][Full Text] [Related]
14. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist.
Gao J; Tian L; Weng G; O'Brien TD; Luo J; Guo Z
Transplant Proc; 2011 Nov; 43(9):3217-20. PubMed ID: 22099761
[TBL] [Abstract][Full Text] [Related]
15. Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?
Trevaskis JL; Turek VF; Griffin PS; Wittmer C; Parkes DG; Roth JD
Physiol Behav; 2010 May; 100(2):187-95. PubMed ID: 20206194
[TBL] [Abstract][Full Text] [Related]
16. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
Maida A; Lamont BJ; Cao X; Drucker DJ
Diabetologia; 2011 Feb; 54(2):339-49. PubMed ID: 20972533
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin on the urinary metabolites of diet-induced-obese mice studied by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF/MS).
Zhu Y; Feng Y; Shen L; Xu D; Wang B; Ruan K; Cong W
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():110-6. PubMed ID: 23523884
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG
Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760
[TBL] [Abstract][Full Text] [Related]
19. Effect of rimonabant and metformin on glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 in obese women with polycystic ovary syndrome.
Sathyapalan T; Cho L; Kilpatrick ES; Le Roux CW; Coady AM; Atkin SL
Clin Endocrinol (Oxf); 2010 Mar; 72(3):423-5. PubMed ID: 19489873
[No Abstract] [Full Text] [Related]
20. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]